Trial intelligence / Profile preview

PARROT trial of prophylactic azithromycin to prevent chest infections in children with neurological impairment

ISRCTN71955516Phase 3Completed

Sponsor
University of Liverpool
Start
Mar 2022
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in pulmonary infection comparing Azithromycin prophylaxis with Placebo (2 arms). Primary endpoint: Hospitalization with lower respiratory tract infection over 52 weeks. Started Mar 2022; status: completed.

02

Drugs

azithromycin
03

Conditions

pulmonary infection

Beyond the preview

Go deeper on ISRCTN71955516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN71955516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call